© Copyright RiverVest® All Rights Reserved.
/ NEWSLETTER
Newsletter Archive
2024
RiverVest Newsletter – October 2024
RiverVest Welcomes Nafise Masoumi as Senior Associate
RiverVest Newsletter – June 2024
2024 Annual Meeting Recap
RiverVest Newsletter – March 2024
RiverVest Invests in Neuroscience Company Engrail Therapeutics
2023
RiverVest Newsletter – November 2023
RiverVest’s Pascal Krotee Wins Life Science Catalyst Award
RiverVest Newsletter – June 2023
RiverVest Year in Review
RiverVest Newsletter – March 2023
RiverVest Co-Leads $75 Million Series A Equity Round for Alleviant Medical
2022
RiverVest Newsletter – Fall 2022
RiverVest Builds Strong Portfolios
RiverVest Newsletter – Summer 2022
RiverVest Hosts 22nd Annual Meeting
2021
2020
RiverVest Newsletter – Summer 2020
RiverVest Celebrates 20 Years of Science, Strategy and Innovation
2019
RiverVest Newsletter – Spring 2019
RiverVest closes on its oversubscribed $184.4 million RiverVest Fund IV
2018
2017
RiverVest Newsletter – Fall/Winter 2017
RiverVest Expands Scientific Advisory Board
RiverVest Newsletter – Winter 2017
RiverVest Closes on $15 Million Biopharma Seed Fund
2016
RiverVest Newsletter – Summer 2016
RiverVest Venture Partners Co-leads $86 Million Series A Financing for St. Louis-founded Startup Tioma
RiverVest Newsletter – Spring 2016
Nanc Hong Joins RiverVest